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Abstract
Hereditary multiple exostosis (HME) is an
autosomal dominant disorder characterized by
two or more benign growing, cartilage capped
tumors of long bones called osteochondromas.
If abnormal growth and clinical symptoms of
osteochondromas newly appear in adults,
malignant transformation of the usually
benign growing tumors should be suspected
and diagnostic testing should be initiated.
Against the background of hypothesized high-
er malignant transformation of osteochondro-
mas into chondrosarcoma in individuals with
shoulder exostoses, we report a case of bilater-
al scapulothoracic osteochondromas in a
patient suffering from HME. A 60-year-old
female with HME complained of chest pain
while being hospitalized for bilateral femoral
fractures. A computed tomography scan of the
chest was performed to rule out pulmonary
embolism. However, bilateral osteochondro-
mas in the scapulothoracic spaces were detect-
ed. Due to absence of radiographic evidences
for malignant transformation in the patient,
invasive diagnostic procedures such as biopsy
and histological examination were recom-
mended in order to exclude malignant trans-
formation of both osteochondromas.
Physicians should be aware that patients with
HME who present with shoulder pain should
be examined for osteochondromas in the
scapulothoracic space. Due to possible sarco-
matous transformation, regular follow-ups are
necessary for adolescents and adults.
Introduction
Hereditary multiple exostosis (HME) is a
rare disease. Since Boyer first described a
family suffering from HME in 1814, epidemio-
logical studies generate the prevalence of the
orphan disorder affecting at least one in
50,000 people.1-4 Most often located in the
proximal humerus, distal femur and proximal
tibia, cartilaginary exostoses arise from
metapyhsal regions of enchondral growing
bones.2,5,6 Osteochondromas increase in size
throughout childhood and stop growing when
skeletal maturity is reached. Number and size
of osteochondromas differ widely in individu-
als and families with known history of HME.
While mean numbers of locations in individu-
als suffering from HME differ between 6 to 18,
osteochondromas usually occur either pedun-
culated or are broad based around areas of
active bone growth.2,6 Although osteochondro-
mas are often clinically asymptomatic, symp-
toms like pain and orthopedic deformities i.e.
differences in bone length, forearm deformi-
ties and varus-valgus malposition of the knee
usually lead to the diagnosis of HME in the
first decade of life.7 If growth and clinical
symptoms of osteochondromas newly appear
in adults, malignant transformation of the usu-
ally benign growing tumors should be suspect-
ed. In up to 8% the malignant degeneration to
chondrosarcoma is described.8 Thus, regular
monitoring and, if malignant tumor growth is
diagnosed, surgical treatment of patients suf-
fering from HME is necessary.8,9 Against the
background of hypothesis that severely affect-
ed patients with HME are associated with pal-
pable shoulder exostoses, we report for the
first time a coincidentally found bilateral for-
mation of osteochondromas in the scapulotho-
racic spaces in a patient suffering from HME.10
Hitherto, no case of bilateral osteochondromas
arising from the scapula forming a scapulotho-
racic neojoint is described in the literature.
Case Report
A 60-year-old woman suffering from heredi-
tary multiple exostosis was referred to our
clinic with bilateral femoral shaft fractures
after falling on ground out of a wheelchair.
Due to an osteochondroma in the cervical
spinal canal resulting in paraplegia of the
lower extremities, the patient was already
bound to the wheelchair for more than 20
years. Thus, sedentary osteoporosis of the 60-
year-old lady most likely resulted in the bilater-
al femoral fracture after inadequate trauma in
home environment. Besides suffering from a
cervical spine osteochondroma resulting in
paraplegia of the lower extremities, cartilagi-
nary exostosis around both knees and the left
proximal humerus were also reported. In 1976
a resection of the humeral cartilaginary exos-
tosis was performed due to malignant transfor-
mation. This resulted in the movement impair-
ment of both, elevation and anteversion of the
left upper extremity up to 90 degrees. The
patient also had a positive family history shar-
ing HME with her father and daughter.
After open reduction and internal plate fixa-
tion of both femoral fractures the patient was
mobilized in our surgical ward. Weight bearing
restrictions were imposed for 12 weeks postop-
eratively. To prevent thrombosis the current
standard-of-care therapy with enoxaparine 40
mg per day was administered to the patient.
During the postoperative treatment the patient
showed typical symptoms of pulmonary
embolism as described by Hunt and Bull.11
As further diagnostics a computed tomogra-
phy (CT) (Siemens Somatom Definition
System, Siemens Medical Solutions, Forchheim,
Germany) was performed. CT parameters were
as follows: detector collimation 40×0.6 mm,
pitch 1.3, rotation time 0.5 s, slice thickness 2
mm and tube voltage 120 kV. Online tube current
modulation was employed to reduce patient
dose. Despite of no evidence for pulmonary
embolism, bilateral osteochondromas arising
from both shoulder blades forming a neojoint in
the scapulothoracic space were detected
(Figures 1 and 2). Interestingly the patient also
showed no signs of malignant growth. In addi-
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tion, neither cortical destruction, moth-eaten
and permeative osteolysis, nor endosteal scallop-
ing was detected. After recognition of this rare
finding, the upper extremity of the patient was
examined in detail. Compared to normal anato-
my a bilateral prominence was marginally visi-
ble, which was well palpable on both sides above
the scapula body. Range of motion of the right
shoulder was not impaired, whereas the move-
ment of the left shoulder was impaired for more
than 30 years as described above. Pressure pain
or movement pain along with motor and sensi-
ble deficits were absent during physical exami-
nation. While hospitalized due to bilateral
femoral fractures pain management and patient
positioning were optimized thereby resulting in
relief of the symptoms. In context with the
detected bilateral scapulothoracic osteochondro-
mas a magnet resonance imaging (MRI) scan
was initiated, but could not be performed due to
patient’s claustrophobia. Further diagnostics
such as biopsy of the bilateral tumors was rec-
ommended but refused by the patient as well.
Discussion
The existence of a variety of synonyms, in
relation to the primarily benign tumor forming
disease, indicates a diverse research interest.
Multiple hereditary osteochondromas, multiple
osteochondromatosis, multiple cartilaginous
exostosis, multiple osteochondromatosis,
familial exostosis and Bessel-Hagen disease
are the most common.2,7 Although 200 years
have elapsed since its first description as
hereditary disease, the origin of HME was not
discovered until the 1990s. Studies could show
a lack of EXT1 and EXT2 genes causes HME.12-
15 Later loss of function of the EXT3 gene was
also identified to be associated with multiple
osteochondromatosis.16 Different kinds of
EXT1 and EXT2 gene mutations were identi-
fied resulting in impaired heparan sulphate
synthesis by lack of exostosin 1 and 2
proteins.13,17 Heparan sulphate proteoglycans
(HSPG) are important mediators for growth
factor binding to chondrocytes. Thus, biosyn-
thesis of HSPGs is in turn a regulatory process
for signal cascades influencing differentiation
and apoptosis of chondrocytes.18,19 Because
development of HME mainly occurs due to lack
of EXT1, EXT2 or EXT3 genes, EXT genes are
designated as tumor suppressor genes.20
However, up to 10-25% HME cases manifests
in families without known history of HME
caused by new mutations (de novo mutation).
Moreover, manifestation of HME seems to be
higher in males (male to female ratio: 1.5:1).
Despite limited information to support EXT
gene penetrance in female subjects, no differ-
ence in penetrance due to sex is described as
well.1,2,7,20-22 While individuals with a mutation
in the EXT1 gene are reported to be more
severely affected by HME, the manifestation of
shoulder exostoses also seems to be more like-
ly in these patients. In addition, malignant sar-
comatous change seems to be most likely in
patients suffering from palpable shoulder
exostoses relative to any other anatomic site.10
Hence, beside its importance as diagnostic
tool, clinical examination even has a prognos-
                             Case Report
Figure 1. Axial (A) and 3D reconstructed (B) computed tomogra-
phy scan. A and B  show  an osteochondroma rising from the left
ventral scapula body forming a scapulothoracic neojoint. Figure 2. Axial (A) and 3D reconstructed (B) computed tomogra-
phy scan showing an osteochondroma in the right scapulotho-
racic space.
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tic relevance. Against this background it is not
unexpected that the patient described above
has a malignant sarcomatous transformation
in her medical history. 
Furthermore, the presented case shows the
topographic occurrence of osteochondromas in
patients suffering from HME. Cartilaginary
exostoses are most likely located around the
knee. The probability of involvement of the
knee in affected individuals is described with
94%.2 Besides location of osteochondromas
close to the knee the cartilage caped bone
tumors are most likely located in the proximal
humerus (50%), proximal forearm (radius
38%, ulna 37%) and distal ulna (80%).5,23,24 The
risk that a patient with HME has a spinal
lesion is described with 27%.25 Numerous case
presentations of vertebral osteochondromas in
children and adults suffering from HME result
in cervical myelopathy thereby showing its
clinical relevance.26-31 Therefore a routinely
performed spinal image screening of HME
patients is recommended.26,32 Concerning
shoulder exostoses, which are most likely
associated with EXT1 gene mutation, and thus
predisposed for sarcomatous change are of
special clinical interest, the reported preva-
lence ranges from 14 to 45%.2,5,10 Among the
rare but severe complications caused by chest
wall osteochondromas as described in the liter-
ature such as spontaneous hemothorax, pneu-
mothorax, extrinsic coronary compression and
spinal cord compression (Table 1),33-39 malig-
nant transformation is the most feared situa-
tion for patients suffering from HME.
According to the possible fateful diagnosis, a
standardized clinical evaluation criteria should
be met as it is usual for bone tumors in gener-
al.40,41 A standardized screening of patients suf-
fering from HME is recommended. Besides
taking patient’s history and performing a
detailed physical examination plain radi-
ographs of areas that cannot be manually
examined, i.e. the chest, pelvis and scapula,
should be performed. If differences are seen in
the regularly performed examinations, further
imaging diagnostics like conventional radi-
ographs should be carried out, followed by
cross-sectional imaging techniques, such as
CT and MRI. If the diagnosed tumor seems to
be aggressive in growth in any case, a MRI
should be done to detect the dimension of the
lesion before performing a biopsy by an ortho-
pedic or surgical specialist. Often growth of
the cartilage cap of an osteochondroma indi-
cates malignant transformation. A millimeter
thick cartilage normally caps the projecting
bone. Although a strict cut-off in terms of
thickness of the cartilaginous cap being
pathognomonic of malignancy does not exist, a
rare transformation of the normally benign
tumor into an epiexostotic chrondrosarcoma
should be suspected, if the cartilage cap is
wider than 2 cm and has grown after adoles-
cence.42-47 In case of confirmed malignancy,
surgical resection of the tumor is necessary as
far as possible. Following which confirmation
of tumor free margins of the resected tissue
has to be done by an experienced pathologist.
En-bloc resection and confirmed complete
margin-free resection show an excellent long-
term clinical result.9,48 As a result of surgical
resection due to sarcomatous change, pain,
functional problems due to nerve and vessel
compression, deformities or even early degen-
erative arthritis may require further orthope-
dic surgical therapy. For conservative treat-
ment, in addition to the standardized pain
management, use of bisphosphonates is con-
sidered to be helpful in management of refrac-
tory pain in patients suffering from HME.49,50 If
conservative treatment is exhausted, depend-
ing on the anatomical site different operative
strategies are discussed.23,51,52 In regard to
shoulder exostoses different kinds of surgical
techniques, open as well as endoscopic mini-
mally invasive procedures, are described.46,53-55
Due to possible malignant transformation and
limited non surgical treatment options in
chondrosarcoma, endoscopic minimally inva-
sive procedures should be regarded with a crit-
ical eye.
Conclusions
In summary, patients suffering from HME
along with shoulder pain should remind exam-
iners of osteochondromas for being the
responsible cause for motion induced pain.
The possibility of sarcomatous change should
be the reason for regular examinations of
patients suffering from HME by specialists.
Hitherto, surgical treatment is the appropriate
measure in case of malignant degeneration
and if necessary for refractory pain and func-
tional impairment.
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